IL17A and COVID-19: In summary, a large body of observational human studies now implicate MAIT cell responses in the immune pathology of COVID-19, with deficiency of circulating MAIT cells, recruitment to the lung, upregulation of activation markers, production of IL-17, TNF and granzyme B, with evidence of MAIT cell exhaustion.